BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9762585)

  • 1. Developmental regulation of mouse brain monomeric acetylcholinesterase.
    Moreno RD; Campos FO; Dajas F; Inestrosa NC
    Int J Dev Neurosci; 1998 Apr; 16(2):123-34. PubMed ID: 9762585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphiphilic properties of acetylcholinesterase monomers in mouse plasma.
    García-Ayllón MS; Gómez JL; Vidal CJ
    Neurosci Lett; 1999 Apr; 265(3):211-4. PubMed ID: 10327168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain.
    Rakonczay Z
    Acta Biol Hung; 2003; 54(2):183-9. PubMed ID: 14535624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monomeric amphiphilic forms of acetylcholinesterase appear early during brain development and may correspond to biosynthetic precursors of the amphiphilic G4 forms.
    Inestrosa NC; Moreno RD; Fuentes ME
    Neurosci Lett; 1994 May; 173(1-2):155-8. PubMed ID: 7936404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development--a study of molecular forms.
    Arendt T; Brückner MK; Lange M; Bigl V
    Neurochem Int; 1992 Oct; 21(3):381-96. PubMed ID: 1303164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholinesterase in Dendrobaena veneta (Oligochaeta: Opisthopora) is present with forms sensitive and insensitive to phosphatidylinositol phospholipase C. Biochemical characterization and histochemical localization in the nervous system.
    Talesa V; Romani R; Rosi G; Giovannini E
    Eur J Biochem; 1996 Jun; 238(2):538-48. PubMed ID: 8681969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential inhibition of acetylcholinesterase molecular forms in rat brain.
    Ogane N; Giacobini E; Messamore E
    Neurochem Res; 1992 May; 17(5):489-95. PubMed ID: 1528356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and properties of monomeric (G1) forms of acetylcholinesterase secreted by Nippostrongylus brasiliensis.
    Grigg ME; Tang L; Hussein AS; Selkirk ME
    Mol Biochem Parasitol; 1997 Dec; 90(2):513-24. PubMed ID: 9476798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of 125I-fasciculin to rat brain acetylcholinesterase. The complex still binds diisopropyl fluorophosphate.
    Marchot P; Khélif A; Ji YH; Mansuelle P; Bougis PE
    J Biol Chem; 1993 Jun; 268(17):12458-67. PubMed ID: 8509385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease.
    Camps P; Cusack B; Mallender WD; El Achab RE; Morral J; Muñoz-Torrero D; Rosenberry TL
    Mol Pharmacol; 2000 Feb; 57(2):409-17. PubMed ID: 10648652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket.
    Ordentlich A; Barak D; Kronman C; Flashner Y; Leitner M; Segall Y; Ariel N; Cohen S; Velan B; Shafferman A
    J Biol Chem; 1993 Aug; 268(23):17083-95. PubMed ID: 8349597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural monomeric form of fetal bovine serum acetylcholinesterase lacks the C-terminal tetramerization domain.
    Saxena A; Hur RS; Luo C; Doctor BP
    Biochemistry; 2003 Dec; 42(51):15292-9. PubMed ID: 14690439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential inhibition of acetylcholinesterase molecular forms in normal and Alzheimer disease brain.
    Ogane N; Giacobini E; Struble R
    Brain Res; 1992 Sep; 589(2):307-12. PubMed ID: 1393597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcholinesterases from Elapidae snake venoms: biochemical, immunological and enzymatic characterization.
    Frobert Y; Créminon C; Cousin X; Rémy MH; Chatel JM; Bon S; Bon C; Grassi J
    Biochim Biophys Acta; 1997 May; 1339(2):253-67. PubMed ID: 9187246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of acetylcholinesterase in Alzheimer's disease with special reference to effect of acetylcholinesterase inhibitor.
    Mimori Y; Nakamura S; Yukawa M
    Behav Brain Res; 1997 Feb; 83(1-2):25-30. PubMed ID: 9062656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A steric blockade model for inhibition of acetylcholinesterase by peripheral site ligands and substrate.
    Rosenberry TL; Mallender WD; Thomas PJ; Szegletes T
    Chem Biol Interact; 1999 May; 119-120():85-97. PubMed ID: 10421442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of acetylcholinesterase molecular forms to inhibition by high MgCl2 concentration.
    Inestrosa NC; Pérez CA; Simpfendorfer RW
    Biochim Biophys Acta; 1994 Oct; 1208(2):286-93. PubMed ID: 7947960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol-acetylcholinesterase-inhibitor interactions: inhibitor hydrophobicity and site specificity dependence.
    Shin S; Roth LG; Chen CH
    Int J Biochem; 1991; 23(10):1131-6. PubMed ID: 1786855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition of soluble and membrane-bound acetylcholinesterase forms from mouse brain by choline esters with an acyl moiety of an intermediate size.
    Cho Y; Cha SH; Sok DE
    Neurochem Res; 1994 Jul; 19(7):799-803. PubMed ID: 7969748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An acetylcholinesterase purified from the greenbug (Schizaphis graminum) with some unique enzymological and pharmacological characteristics.
    Gao JR; Zhu KY
    Insect Biochem Mol Biol; 2001 Oct; 31(11):1095-104. PubMed ID: 11520688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.